Stay updated on Pembrolizumab in Recurrent HNSCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent HNSCC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.3.3 to v3.3.4; no visible changes to study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:48:37.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now displays a new revision note 'Revision: v3.3.3' in the footer, and the 'HHS Vulnerability Disclosure' link along with the prior 'Revision: v3.3.2' note were removed.
    Difference
    0.1%
    Check dated 2025-12-23T10:17:36.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:52:26.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.1 and the previous Revision: v3.2.0 label was removed.
    Difference
    0.1%
    Check dated 2025-11-24T14:51:04.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Removed the government funding and operating status notice from the page; core study details are unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:58:27.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The screenshots show only cosmetic/UI layout updates with no changes to core study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:22:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent HNSCC Clinical Trial page.